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Abstract
Background: Spontaneous splenic rupture associated with anticoagulant use is a rare but potentially lethal
disorder. Lack of prompt recognition can be associated with poor patient outcomes. The use of novel oral
anticoagulants is becoming more common and thus consideration of this disorder while evaluating a patient
who presents with abdominal pain while using these agents is extremely important. This is the first reported
case of spontaneous splenic rupture associated with apixaban.
Case presentation: We describe the clinical case of an 83-year-old white man who complained of sudden
severe abdominal pain 5 days into a hospital stay for acute-on-chronic congestive heart failure and exacerbation
of chronic obstructive pulmonary disease. Neither he nor his wife reported any significant trauma for the past 6
months prior to his admission. His medical history included chronic atrial fibrillation treated with medications
including apixaban 2.5 mg twice daily. An urgent abdominal computed tomography scan demonstrated a
large splenic hematoma and evidence of intraperitoneal bleeding from which he rapidly declined, developing
hypovolemic shock. An emergency splenic arteriogram displayed a patent splenic artery and an embolization was
successful in stabilizing him. Due to evidence of recurrent bleeding, an exploratory laparotomy and splenectomy
was subsequently performed the following day.
Conclusions: The diagnosis of spontaneous splenic rupture is important to consider in a patient using apixaban
who presents with abdominal pain and associated signs of hypotension and anemia. For hemodynamically
unstable patients, prompt treatment to stop significant bleeding through splenic artery embolization or
splenectomy is warranted and may be lifesaving.
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Background
In prior studies, the most common etiology of sponta-
neous splenic rupture was due to hematologic malignan-
cies. In one systematic review, in only 9.1 % of patients
were spontaneous splenic ruptures associated with drug
and treatment-related causes and these included the use
of anticoagulants, granulocyte-colony stimulating factors,
thrombolytics, and dialysis [1]. In a more recent retro-
spective study, 33 % of cases of spontaneous splenic
rupture were associated with anticoagulant-antiaggregant
use [2]. Spontaneous splenic rupture associated with
anticoagulant or thrombolytic therapy, although rare, has
been well documented and may be more frequent than
initially believed [2, 3]. Despite this, spontaneous splenic
rupture associated with novel anticoagulants such as
factor Xa inhibitors remains a relatively new occurrence
[4, 5]. To date, there have been no published cases of
spontaneous splenic rupture that have been found to be
associated with the factor Xa inhibitor, apixaban.
Apixaban is a direct and competitive inhibitor of factor
Xa indicated for the prevention of stroke in patients with
a history of non-valvular atrial fibrillation, prevention of
thromboembolism for those who have undergone recent
knee or hip replacement surgery, and treatment of acute
deep venous thrombosis/pulmonary embolism in appro-
priate patients [6, 7]. Here we present a case of sponta-
neous splenic rupture in an 83-year-old man who was
on apixaban for stroke prophylaxis due to chronic atrial
fibrillation.
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Case presentation
An 83-year-old white man presented to our emergency
department with shortness of breath. His past medical
history was significant for chronic obstructive pulmonary
disease, atrial fibrillation, congestive heart failure, anemia of
chronic disease, sick sinus syndrome, pulmonary hyperten-
sion, and chronic kidney disease. His medications included
probenecid, finasteride, albuterol-ipratropium bromide by
inhalation, furosemide, carvedilol, omeprazole, tamsulosin,
mirtazapine, ferrous sulfate, metolazone, losartan, budeso-
nide, and prednisone. He was also on apixaban 2.5 mg
twice daily for anticoagulation due to non-valvular atrial
fibrillation. He did not have a history of bleeding or clotting
disorders, although he had presented to our emergency
department with complaints of hemoptysis at least once
previously due to his cardiopulmonary disease.
Acute-on-chronic congestive heart failure and exacer-
bation of chronic obstructive pulmonary disease were
diagnosed. Five days into his hospital stay he awoke with
diffuse abdominal pain. He and his wife both denied
history of recent abdominal or chest trauma, including
falls. After the onset of his abdominal pain, while sitting
up in bed, he had a witnessed syncopal event and be-
came unresponsive. A medical emergency response team
was called to his bedside and laboratory tests were imme-
diately performed. He recovered and was stabilized, but
soon after he developed abdominal distention, tympanic
bowel sounds, and altered mental status. He decompen-
sated rapidly with a drop in blood pressure from baseline
values of 100/50 mm Hg to 54/32 mm Hg. An immediate
abdominal computed tomography (CT) scan was com-
pleted at that time with the differential diagnosis being
considered including bleeding gastric or duodenal ulcer,
ischemic bowel, myocardial infarction, or septic shock.
His CT showed a splenic hematoma with associated
enlargement of his spleen measuring 13.6×11.5×15.5 cm
and blood in his abdominal cavity (Fig. 1). On hematologic
tests, his serum hemoglobin was reduced from his baseline
value of 9.3 g/dL on admission to 5.3 g/dL (normal range
13.5 to 18 g/dL). His activated partial thromboplastin time
(aPTT) was within normal range; however, his prothrom-
bin time (PT) was elevated at 16.1 seconds (normal range,
9.5 to 12.7 seconds) consistent with his use of apixaban.
Rapid transfusion of two units of packed red blood
cells, followed by three units of fresh frozen plasma was
initiated. Despite attempts at resuscitation, he remained
hypotensive and in shock. Due to multiple comorbidities
which could potentially complicate surgical intervention,
he was urgently transferred to interventional radiology
for an emergency splenic artery embolization. An angio-
gram completed during the procedure showed a splenic
artery that was patent and tortuous, with medial displace-
ment of his spleen by a hematoma consistent with what
was seen on CT imaging. He was successfully stabilized by
embolization of the bleeding source; he was subsequently
transferred to our intensive care unit.
The following morning, subsequent to the embolization
of the bleeding source, his hemoglobin had decreased
from 8.6 g/dL to 6.6 g/dL, which raised a concern that he
had recurrent bleeding; a laparotomy was performed with
a splenectomy and evacuation of a large intra-abdominal
hematoma. During the procedure, 3600 mL of blood and
clots were evacuated from his abdominal cavity.
Following the surgery, he underwent prolonged mech-
anical ventilation due to respiratory failure and temporary
hemodialysis for acute-on-chronic kidney injury. He was
eventually discharged to a short-term rehabilitation facility
for physical therapy after an extensive hospitalization.
Discussion
Spontaneous splenic rupture is a rare event in the health
care setting. The literature has cited hematological,
infectious, and neoplastic disorders as common causes of
spontaneous splenic ruptures [1, 8]. Medical procedures
such as colonoscopy, endoscopic retrograde cholangiopan-
creatography, and hysterectomy have also been frequent
Fig. 1 Computed tomography of the patient’s abdomen with splenic rupture and evidence of intra-abdominal bleeding
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etiologies of spontaneous splenic rupture [8]. In addition,
splenomegaly, as was seen in our patient, was a common
feature in many reported cases, affecting approximately 55
% of patients in one systematic review [1].
As stated previously in the Background section,
anticoagulant therapies continue to be linked to in-
stances of spontaneous splenic rupture. Several reports
have described spontaneous splenic ruptures in relation
to anticoagulant therapy with heparin and its derivatives
[9–11]. Anti-fibrinolytic therapy with tissue plasminogen
activator and streptokinase has also been associated with
spontaneous splenic rupture [12, 13]. While the patho-
physiology for spontaneous splenic rupture remains largely
unknown in many instances, one theory states that a spleen
with previous microtrauma may rupture when placed
under different hematic conditions as is seen in anticoagu-
lant, thrombolytic, or anti-fibrinolytic therapies [14].
Previous data have cited abdominal pain and hypotension
as the most common features seen in patients presenting
with an acute episode of spontaneous splenic rupture, with
approximately 50 % of described patients presenting with
abdominal pain referred to their left shoulder [3, 15]. One
recent study cited 100 % of patients presenting with
spontaneous splenic rupture as having a predominant
complaint of abdominal pain [2]. Other studies showed 95 %
of patients presented with abdominal pain, 66 % with
hypotension, and some with features of hemorrhagic shock
[14, 16]. Due to common symptoms, spontaneous splenic
rupture may initially be confused with a cardiac etiology or
suspected perforated peptic ulcer. Without a history of
trauma pointing to the possibility of a ruptured spleen,
treatment is often delayed, particularly in patients with a
history of cardiac or gastrointestinal issues [3, 14]. Due to
the strong correlation between abdominal pain and splenic
rupture, contemplation of this diagnosis is warranted in any
patient who is on anticoagulation presenting with abdominal
pain.
In general, the recommended treatment for splenic
rupture includes emergent laparotomy for those who are
hemodynamically unstable. As in our case, 17 % of conser-
vatively treated patients underwent secondary splenectomy
because of re-bleeding and progressive hemodynamic in-
stability [1]. For hemodynamically stable patients without
peritonitis or signs of active hemorrhage on CT, close
observation is acceptable [17]. In the future, reversal agents
for factor Xa inhibitors may be useful for treatment of this
disorder.
Conclusions
This clinical case demonstrates the importance of prompt
recognition of a spontaneous splenic rupture in a patient
on anticoagulation with apixaban. Consideration of this
diagnosis should be entertained in any patient with
abdominal pain who is on anticoagulation, even if there is
no history of trauma. Close observation may be done for
those patients who are hemodynamically stable, but more
invasive treatment should be available and considered if
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